CYP1A1和CYP2E1基因多态与胃癌易感性关系的研究
Research on Association of Genetic Polymorphism of CYP1A1 and CYP2E1, with Susceptibility to Gastric Cancer

作者: 宋浩瑞 , 吴 双 :河北省唐山市第一中学,河北 唐山; 张佳桢 :河北省唐山市龙泉中学,河北 唐山; 曹 蕾 :华北理工大学生命科学院,河北 唐山;

关键词: CYP1A1CYP2E1单核苷酸多态胃癌易感性细胞色素P450CYP1A1 CYP2E1 Single Nucleotide Polymorphism Gastric Cancer Susceptibility Cytochrome P450

摘要:
目的:探讨细胞色素P450 (CYP450)基因CYP1A1第7外显子的Ile462Val (rs1048943)以及CYP2E1-1239G>C (rs3813867)单核苷酸多态(SNP)与胃癌遗传易感性的相关关系。方法:采用病例–对照研究,聚合酶链反应–限制性片断长度多态性分析(PCR-RFLP)方法,分析230例胃癌患者和460例正常对照者的CYP1A1基因Ile462Val以及CYP2E1基因-1239G>C位点的基因型。以比值比(OR)及其95%可信区间(CI)比较不同基因型与胃癌发病风险的相关关系。结果:与CYP1A1 462 Ile/Ile基因型携带者相比,462 Val/Val基因型携带者胃癌发病风险显著降低,其OR值分别为0.31 (95% CI: 0.16 − 0.60; P = 0.001)。吸烟分层分析显示,在吸烟人群中,至少携带一个462Val等位基因的基因者与未携带者相比,发生胃癌的风险显著降低了59% (OR = 0.41, 95%CI = 0.24 − 1.43; P = 0.001);且这种保护作用在重度吸烟患者中尤为明显(OR = 0.29, 95% CI = 0.14 − 0.64; P = 0.002)。而CYP2E1-1239G>C各基因型分布在正常人群和胃癌患者中差异无统计学意义(P > 0.05)。CYP1A1基因Ile462Val变异是影响胃癌易感性的重要因素。

Abstract: Objective: To investigate the association of CYP1A1 Ile462Val and CYP2E1-1239G>C polymor-phisms with gastric cancer (GC) in Chinese population. Methods: The study included 230 cases with GC and 460 frequency-matched controls. The polymerase chain reaction-restriction frag-ment length polymorphism (PCR-RFLP) method was used to analyze genotype CYP1A1 Ile462Val and CYP2E1-1239G>C polymorphisms. The odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression model. Results: Compared with the CYP1A1 462 Ile/Ile genotype carriers, the subjects with 462 Val/Val genotype carriers have de-creased risk for gastric cancer, with the 0.31 of OR and 0.16 - 0.60 of 95% CI. When stratified by smoking status, subjects with at least one 462Val allele carrier had a reduced risk of developing GC (OR = 0.29, 95% CI = 0.14 - 0.64) among heavy smokers, but not among non-smokers. There was no significant difference in CYP2E1-1239G>C genotype distribution between gastric cancer cases and the control. Conclusion: CYP1A1 Ile462Val polymorphism is associated with the sus-ceptibility to GC in Chinese population.

文章引用: 宋浩瑞 , 张佳桢 , 吴 双 , 曹 蕾 (2016) CYP1A1和CYP2E1基因多态与胃癌易感性关系的研究。 亚洲肿瘤科病例研究, 5, 72-78. doi: 10.12677/ACRPO.2016.54008

参考文献

[1] Siegel, R., Naishadham, D. and Jemal, A. (2012) Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10-29.
http://dx.doi.org/10.3322/caac.20138

[2] Crew, K.D. and Neugut, A.I. (2006) Epidemiology of Gastric Cancer. World Journal of Gastroenterology, 12, 354-362.
http://dx.doi.org/10.3748/wjg.v12.i3.354

[3] 庞莉萍, 崔景荣. 细胞色素P450 1A1的研究进展[J]. 国外医学遗传学分册, 2005, 28(2): 80-83.

[4] Aktas, D., Guney, I., Alikasifoglu, M., Yuce, K., Tuncbilek, E. and Ayhan, A. (2002) Cyp1a1 Gene Polymorphism and Risk of Epithelial Ovarian Neoplasm. Gynecologic Oncology, 86, 124-128.
http://dx.doi.org/10.1006/gyno.2002.6720

[5] Sato, M., Sato, T., Izumo, T. and Amagasa, T. (2000) Genetically High Susceptibility to Oral Squamous Cell Carcinoma in Terms of Combined Genotyping of Cyp1a1 and Gstm1 Genes. Oral Oncology, 36, 267-271.
http://dx.doi.org/10.1016/S1368-8375(99)00090-1

[6] Brasch, R.C. (1992) New Directions in the Development of MR Imaging Contrast Media. Radiology, 183, 1-11.
http://dx.doi.org/10.1148/radiology.183.1.1549653

[7] Zhan, P., Wang, J., Zhang, Y., Qiu, L.X., Zhao, S.F., Qian, Q., Wei, S.Z., Yu, L.K. and Song, Y. (2010) Cyp2e1 Rsa I/Pst I Polymorphism Is Associated with Lung Cancer Risk among Asians. Lung Cancer, 69, 19-25.
http://dx.doi.org/10.1016/j.lungcan.2009.09.001

[8] Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H. and Alexandrov, K. (2000) Genetic Polymorphism of Cyp Genes, Alone or in Combination, as a Risk Modifier of Tobacco-Related Cancers. Cancer Epidemiology, Biomarkers & Prevention, 9, 3-28.

[9] Cantor, K.P., Villanueva, C.M., Silverman, D.T., Figueroa, J.D., Real, F.X., Garcia-Closas, M., Malats, N., Chanock, S., Yeager, M., Tardon, A., Garcia-Closas, R., Serra, C., Carrato, A., Castano-Vinyals, G., Samanic, C., Rothman, N. and Kogevinas, M. (2010) Polymorphisms in GSTT1, GSTZ1, and CYP2E1, Disinfection By-Products, and Risk of Bladder Cancer in Spain. Environmental Health Perspectives, 118, 1545-1550.
http://dx.doi.org/10.1289/ehp.1002206

[10] Guo, X., Zeng, Y., Deng, H., Liao, J., Zheng, Y., Li, J., Kessing, B. and O’Brien, S.J. (2010) Genetic Polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the Risk of Nasopharyngeal Carcinoma in a Han Chinese Population of Southern China. BMC Research Notes, 3, 212.
http://dx.doi.org/10.1186/1756-0500-3-212

[11] Wu, R.M., Cheng, C.W., Chen, K.H., Shan, D.E., Kuo, J.W., Ho, Y.F. and Chern, H.D. (2002) Genetic Polymorphism of the CYP2E1 Gene and Susceptibility to Parkinson’s Disease in Taiwanese. Journal of Neural Transmission, 109, 1403-1414.
http://dx.doi.org/10.1007/s00702-002-0721-8

[12] Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N. and Watanabe, J. (1990) Identification of Genetically High Risk Individuals to Lung Cancer by DNA Polymorphisms of the Cytochrome P450IA1 Gene. FEBS Letters, 263, 131-133.
http://dx.doi.org/10.1016/0014-5793(90)80721-T

[13] 何冰, 林佳, 曹蕾, 饶娟, 刘英文, 张志. CYP1A1 Ile462Val多态与小细胞肺癌遗传易感性相关[J]. 卫生研究, 2014, 43(3): 393-396.

[14] Li, H., Chen, X.L. and Li, H.Q. (2005) Polymorphism of Cypia1 and GSTM1 Genes Associated with Susceptibility of Gastric Cancer in Shandong Province of China. World Journal of Gastroenterology, 11, 5757-5762.
http://dx.doi.org/10.3748/wjg.v11.i37.5757

[15] Smith, G.B., Harper, P.A., Wong, J.M., Lam, M.S., Reid, K.R., Petsikas, D. and Massey, T.E. (2001) Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms. Cancer Epidemiology, Biomarkers & Prevention, 10, 839-853.

[16] Raunio, H., Hakkola, J., Hukkanen, J., Lassila, A., Paivarinta, K., Pelkonen, O., Anttila, S., Piipari, R., Boobis, A. and Edwards, R.J. (1999) Expression of Xenobiotic-Metabolizing CYPs in Human Pulmonary Tissue. Experimental and Toxicologic Pathology, 51, 412-417.
http://dx.doi.org/10.1016/S0940-2993(99)80031-1

分享
Top